Preclinical and Phase 1 clinical characterization of CI-979/ RU35926, a novel muscarinic agonist for the treatment of Alzheimer's disease

This publication has 11 references indexed in Scilit:

• A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group
  Published by American Medical Association (AMA) ,1994
• Chapter 54: Subtype selective muscarinic agonists: potential therapeutic agents for Alzheimer's disease
  Published by Elsevier ,1993
• A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group
  JAMA, 1992
• A Double-Blind, Placebo-Controlled Multicenter Study of Tacrine for Alzheimer's Disease
  New England Journal of Medicine, 1992
• Coupling of ml Muscarinic Receptors to G Protein in Alzheimer Disease
  Alzheimer Disease & Associated Disorders, 1991
• Cognition activators
  Medicinal Research Reviews, 1988
• The Cholinergic Hypothesis of Geriatric Memory Dysfunction
  Science, 1982
• Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
  Annals of Neurology, 1981
• Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.
  BMJ, 1978
• SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
  Published by Elsevier ,1976